Receiving feedback about thinking and memory problems experienced by cancer survivors: Randomised pilot study

Not Applicable

Recruiting

• Conditions: Breast cancer; Cancer - Breast

• Registration Number: ACTRN12621000238875
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-08
• Last Update Posted: 24 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Women greater than or equal to 18 years, completed adjuvant chemotherapy for breast cancer within past 36 months, self-report cognitive impairment in the past 7 days on the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire, attribute cognitive dysfunction to cancer and/or cancer treatment, speak and read English fluently, have access to a computer with internet access and an active email account

Exclusion Criteria

Ongoing cancer treatment (ongoing Herceptin or similar targeted therapies, or hormonal therapies are allowable if on stable dose for at least 2 months), history of neurological disorder, current psychiatric disorder that would interfere with study participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported cognitive impairment on Perceived Cognitive Impairments subscale from Functional Assessment of Cancer Therapy – Version 3[Baseline (pre-intervention), 1 week after receiving feedback, 5 weeks after receiving feedback (primary timepoint), and 5 months after receiving feedback]